The new orphan drug Spevigo (spesolimab) that is being imported by ‘Boehringer Ingelheim Korea has received domestic marketing authorization in Korea.

The Ministry of Food and Drug Safety (Minister Yu-Kyung Oh) approved the new orphan drug Spevigo on the 9th.

Generalized Pustular Psoriasis (GPP) is characterized by systemic inflammation affecting the skin and internal organs. Its symptoms include diffuse erythema, fever, neutropenia, and skin pain.

Spevigo is the first drug approved for GPP in Korea, and the drug is approved as a treatment for adult GPP patients who experience rapid worsening of their conditions.

Spevigo is a humanized antagonistic